Home 5 Lab Industry Report 5 FDA-lir 5 FDA Watch: New Guidance on Charging for Investigational Drugs

FDA Watch: New Guidance on Charging for Investigational Drugs

by | Aug 31, 2022

On August 21, the FDA proposed new guidelines on charging for investigational drugs; here are the key highlights.

This content is exclusive to Lab Industry Report subscribers

Start a Free Triall for immediate access to this article and our entire archive of over 20 years of LIR reports.